Editas Medicine Inc (EDIT): What the Financials Tell Us
Editas Medicine Inc (NASDAQ:EDIT) saw a downside of -9.49% to close Monday at $7.11 after subtracting -$0.74 on the day. The 5-day average trading volume is 1,458,400 shares of the company’s common stock. It has gained $8.11 in the past week and touched a new high 3 times within the past 5 days. An average […]
Editas Medicine Inc. (EDIT) Reached A New High 2 times During The Past Five Days
As of Thursday close, Editas Medicine Inc.’s (NASDAQ:EDIT) stock was up $0.05, moving up 0.63 percent to $8.00. The average number of shares traded per day over the past five days has been 1,739,680 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.40 fall in that time frame. […]
Analyzing Editas Medicine Inc. (EDIT) By Technical Indicators
As of Wednesday close, Editas Medicine Inc.’s (NASDAQ:EDIT) stock was down -$0.26, moving down -2.97 percent to $8.50. The average number of shares traded per day over the past five days has been 1,228,040 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.34 fall in that time frame. […]
What Can We Learn From Editas Medicine Inc. (EDIT)’s Valuation Ratios?
Editas Medicine Inc. (NASDAQ:EDIT) finished Friday with an addition of $0.02 to close at $8.68, an upside of 0.23 percent. An average of 1,464,940 shares of common stock have been traded in the last five days. There was a fall of -$0.37 in the past week, and it reached a new high 1 time over […]
Editas Medicine Inc. (EDIT): Technicals Say You should Hold
Editas Medicine Inc. (NASDAQ:EDIT) saw a downside of -5.91% to $8.52 after subtracting -$0.53 on Monday. The 5-day average trading volume is 1,735,919 shares of the company’s common stock. It has gained $9.52 in the past week and touched a new high 3 times within the past 5 days. An average of 1,393,100 shares of […]
